Literature DB >> 10024339

Kidney aminopeptidase A and hypertension, part II: effects of angiotensin II.

L Song1, D P Healy.   

Abstract

Aminopeptidase A (APA) is the principal enzyme that metabolizes angiotensin II (Ang II) to angiotensin III. Previously, we showed that kidney APA was elevated in spontaneously hypertensive rats and was reduced after angiotensin-converting enzyme inhibition. In the present study, we sought to determine whether kidney APA expression was altered after chronically elevated Ang II, either exogenously delivered via osmotic minipumps or endogenously produced in two-kidney, one clip (2K1C) hypertensive rats. Ang II (200 ng. kg-1. min-1) was infused subcutaneously for 1 or 2 weeks by osmotic minipumps, and 2K1C rats were tested 4 weeks after unilateral renal artery clipping. Blood pressure was not significantly elevated in the Ang II-infused animals but was significantly increased at 3 and 4 weeks in the 2K1C animals. APA was significantly elevated approximately 2-fold in kidney cortical membranes from Ang II-infused animals but was decreased 45% in the clipped kidney and 18% in the nonclipped kidneys from 2K1C animals. Isolated glomeruli from Ang II-infused animals and the nonclipped kidneys from 2K1C animals had markedly higher APA activity and immunoreactivity. Likewise, histochemical and immunohistochemical studies indicated that APA levels were increased in glomeruli from angiotensin-infused animals and in both nonclipped and clipped kidneys from 2K1C animals. In contrast, tubular APA was decreased in tubular elements from 2K1C animals, most markedly in the clipped kidneys. Thus, despite the increase in glomerular APA expression in kidneys from 2K1C animals, the decrease in tubular APA expression is more extensive and accounts for the measured reduction in total APA in cortical homogenates. Because clipped kidneys are not exposed to high blood pressure, these results suggest that glomerular APA expression is positively regulated and tubular APA negatively regulated by Ang II. These results further suggest that changes in kidney APA expression could influence the progression of angiotensin-dependent hypertension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024339     DOI: 10.1161/01.hyp.33.2.746

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

1.  Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney.

Authors:  Nadja Grobe; Khalid M Elased; David R Cool; Mariana Morris
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

Review 2.  The importance of the intrarenal renin-angiotensin system.

Authors:  Juan Carlos Q Velez
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-09

Review 3.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

Review 4.  Role of central and peripheral aminopeptidase activities in the control of blood pressure: a working hypothesis.

Authors:  Manuel Ramírez; Isabel Prieto; Francisco Alba; Francisco Vives; Inmaculada Banegas; Marc de Gasparo
Journal:  Heart Fail Rev       Date:  2008-03-29       Impact factor: 4.214

5.  Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors.

Authors:  Brandon A Kemp; John F Bell; Daniele M Rottkamp; Nancy L Howell; Weijian Shao; L Gabriel Navar; Shetal H Padia; Robert M Carey
Journal:  Hypertension       Date:  2012-06-11       Impact factor: 10.190

6.  Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

Authors:  Jan Wysocki; Anne Goodling; Mar Burgaya; Kathryn Whitlock; John Ruzinski; Daniel Batlle; Maryam Afkarian
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-03

7.  Endothelial metabolism of angiotensin II to angiotensin III, not angiotensin (1-7), augments the vasorelaxation response in adrenal cortical arteries.

Authors:  Phillip G Kopf; William B Campbell
Journal:  Endocrinology       Date:  2013-10-03       Impact factor: 4.736

8.  Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.

Authors:  Mahmoud S Alghamri; Mariana Morris; J Gary Meszaros; Khalid M Elased; Nadja Grobe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

9.  Prospective evaluation of aminopeptidase activities in plasma and peripheral organs of streptozotocin-induced diabetic rats.

Authors:  L Zambotti-Villela; S C Yamasaki; J S Villarroel; R F Alponti; P F Silveira
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

Review 10.  Nonclassical renin-angiotensin system and renal function.

Authors:  Mark C Chappell
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.